These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29125064)

  • 1. Pulmonary aerosol delivery and the importance of growth dynamics.
    Haddrell AE; Lewis D; Church T; Vehring R; Murnane D; Reid JP
    Ther Deliv; 2017 Dec; 8(12):1051-1061. PubMed ID: 29125064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery.
    Lip Kwok PC
    Curr Pharm Des; 2015; 21(27):3945-54. PubMed ID: 26290198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by Inhalation.
    Sosnowski TR
    Curr Pharm Des; 2016; 22(17):2453-62. PubMed ID: 26818874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro aqueous fluid-capacity-limited dissolution testing of respirable aerosol drug particles generated from inhaler products.
    Arora D; Shah KA; Halquist MS; Sakagami M
    Pharm Res; 2010 May; 27(5):786-95. PubMed ID: 20229134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review.
    Mansour HM; Hickey AJ
    AAPS PharmSciTech; 2007 Nov; 8(4):E99. PubMed ID: 18181559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of aerosol size during inhalation: hygroscopic growth of commercial nebulizer formulations.
    Haddrell AE; Davies JF; Miles RE; Reid JP; Dailey LA; Murnane D
    Int J Pharm; 2014 Mar; 463(1):50-61. PubMed ID: 24406674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model of the deposition of aerosol particles in the respiratory tract of the rat. II. Hygroscopic particle deposition.
    Ferron GA; Upadhyay S; Zimmermann R; Karg E
    J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):101-19. PubMed ID: 23550602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Pulmonary Cell Culture in Pharmaceutical Inhalation Aerosol Delivery: 2-D, 3-D, and In Situ Bioimpactor Models.
    Acosta MF; Muralidharan P; Meenach SA; Hayes D; M-Black S; Mansour HM
    Curr Pharm Des; 2016; 22(17):2522-31. PubMed ID: 26831643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery.
    Odziomek M; Sosnowski TR; GradoĊ„ L
    Int J Pharm; 2012 Aug; 433(1-2):51-9. PubMed ID: 22580211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical perspectives on pulmonary systemic and macromolecular delivery.
    Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment methods of inhaled aerosols: technical aspects and applications.
    Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges.
    Ruge CA; Kirch J; Lehr CM
    Lancet Respir Med; 2013 Jul; 1(5):402-13. PubMed ID: 24429205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.
    Labiris NR; Dolovich MB
    Br J Clin Pharmacol; 2003 Dec; 56(6):600-12. PubMed ID: 14616419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: an in vitro study.
    Murgia X; Gastiasoro E; Mielgo V; Alvarez-Diaz F; Lafuente H; Valls-i-Soler A; Gomez-Solaetxe MA; Larrabe JL; Rey-Santano C
    J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):81-7. PubMed ID: 21410324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation.
    Rabinowitz JD; Lloyd PM; Munzar P; Myers DJ; Cross S; Damani R; Quintana R; Spyker DA; Soni P; Cassella JV
    J Pharm Sci; 2006 Nov; 95(11):2438-51. PubMed ID: 16886198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of Particle Size on Inhalation of Environmental Aerosol and Impact on Deposition Fraction.
    Haddrell AE; Davies JF; Reid JP
    Environ Sci Technol; 2015 Dec; 49(24):14512-21. PubMed ID: 26568475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advantages and difficulties of aerosol therapy].
    Huchon G
    Rev Prat; 1992 Sep; 42(13):1657-61. PubMed ID: 1455137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The function and performance of aqueous aerosol devices for inhalation therapy.
    Carvalho TC; McConville JT
    J Pharm Pharmacol; 2016 May; 68(5):556-78. PubMed ID: 27061412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.